Tango Therapeutics (TNGX) had its price target raised by Wedbush from $15.00 to $19.00. They now have an "outperform" rating on the stock.
Tango Therapeutics (TNGX) had its price target raised by Guggenheim from $18.00 to $20.00. They now have a "buy" rating on the stock.
Tango Therapeutics (TNGX) had its price target raised by HC Wainwright from $13.00 to $27.00. They now have a "buy" rating on the stock.
Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..